Safety, Tolerability, and Pharmacokinetics of CAL056 Mesylate in Patients With Resistant or Refractory Solid Tumors
Clinical trial NCT04686383 · COMPLETED
Trial details
- NCT number
- NCT04686383
- Sponsor
- Calgent Biotechnology Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-29
- Primary completion
- 2022-06-07
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.